15:43 Dec 20
Infinium Pharmachem Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Infinium Pharmachem Ltd.
Industry Pharmaceuticals
15:43 Dec 20
Quality
0/100
Not Eligible
Valuation
4/100
Expensive Valuation
Technical
52/100
Technically Neutral
Strength
3
Weakness
6
Opportunity
0
Threats
0
19.22 %
ROE %
13.22 %
ROA %
0.00
EPS
42.24
BVPS
8.33 %
Net Profit Margin
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
|---|---|---|---|---|---|---|
| Net Sales | 38.84 | 70.53 | 99.12 | 114.22 | 135.64 | |
| Operating Expenses + | 36.36 | 65.57 | 89.09 | 98.18 | 117.11 | |
| Raw Material | 31.17 | 57.91 | 78.36 | 80.17 | 108.05 | |
| Increase Decrease in Cost | -1.04 | -3.06 | -1.62 | 0.4 | -4.95 | |
| Other Manufacturing Expense | 0 | 0 | 0 | 0 | 0 | |
| Employee Cost | 2.09 | 2.75 | 3.54 | 5.37 | 5.91 | |
| Miscellaneous Expenses | 9.88 | 39.83 | 57.09 | 29.52 | 26.54 | |
| Operating Profit | 2.48 | 4.96 | 10.03 | 16.04 | 18.53 | |
| Other Income | 0.57 | 0.62 | 0.93 | 1.35 | 1.54 | |
| Depreciation | 0.58 | 0.65 | 0.63 | 1.34 | 2.67 | |
| Interest | 1.24 | 1.16 | 1.7 | 3.1 | 2.19 | |
| Profit before tax and exceptio.. | 1.24 | 3.77 | 8.63 | 12.95 | 15.21 | |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | |
| PBT | 1.24 | 3.77 | 8.63 | 12.95 | 15.21 | |
| Provision for Taxation | 0.37 | 1.04 | 1.95 | 3.14 | 3.71 | |
| Net Profit | 0.87 | 2.73 | 6.69 | 9.82 | 11.5 | |
| NET Profit after MI | 0.93 | 2.72 | 6.11 | 9.49 | 11.3 | |
| EPS | 9.19 | 26.8 | 60.07 | 18.67 | 8.12 | |
| Operating Profit Margin (%) | 6.39 | 7.03 | 10.12 | 14.04 | 13.66 | |
| Net Profit Margin (%) | 2.39 | 3.86 | 6.16 | 8.31 | 8.33 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | Mar 24 | |
|---|---|---|
| Promoter | 73.00 | 73.00 |
| FII | 0.00 | 0.00 |
| MF | 0.00 | 0.00 |
| Public | 26.90 | 27.00 |
| Others | 0.10 | 0.00 |
| Others | 0.00 | 0.00 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
